Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options.

Ghavimi, Shima; Apfel, Tehila; Azimi, Hamed; Persaud, Alana; Pyrsopoulos, Nikolaos T

Ghavimi, Shima; Apfel, Tehila; Azimi, Hamed; Persaud, Alana; Pyrsopoulos, Nikolaos T.

Afiliación

Ghavimi S; Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
Apfel T; Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
Azimi H; Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
Persaud A; Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
Pyrsopoulos NT; Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.

J Clin Transl Hepatol ; 8(2): 168-176, 2020 Jun 28.

Article en En | MEDLINE | ID: mdl-32832397

Palabras clave

Adoptive; Carcinoma; Hepatocellular; Immunotherapy; Nivolumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_cobertura_universal Idioma: En Revista: J Clin Transl Hepatol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google